Lorna Proudfoot Selected Research

Inflammation (Inflammations)

1/2013	Zinc oxide nanoparticles and monocytes: impact of size, charge and solubility on activation status.
8/2004	Expression of C-reactive protein in human lung epithelial cells and upregulation by cytokines and carbon particles.
1/2002	Anti-inflammatory responses and oxidative stress in Nippostrongylus brasiliensis-induced pulmonary inflammation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lorna Proudfoot Research Topics

Disease

3	Infections 09/2017 - 01/2002
3	Inflammation (Inflammations) 01/2013 - 01/2002
2	Necrosis 09/2017 - 01/2002
1	Disease Susceptibility (Diathesis) 10/2017
1	Bacterial Infections (Bacterial Infection) 09/2017
1	Smallpox (Variola) 06/2016
1	Anthrax 06/2016
1	Plague (Bubonic Plague) 06/2016
1	Tularemia 06/2016

Drug/Important Bio-Agent (IBA)

2	Antimicrobial Cationic PeptidesIBA 10/2017 - 06/2016
2	Antiviral Agents (Antivirals)IBA 09/2017 - 06/2016
2	CathelicidinsIBA 09/2017 - 06/2016
1	protegrin-1IBA 09/2017
1	Peptides (Polypeptides)IBA 09/2017
1	LipopolysaccharidesIBA 06/2016
1	DefensinsIBA 06/2016
1	HLA-DR Antigens (HLA-DR)IBA 01/2013
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 08/2004
1	C-Reactive ProteinIBA 08/2004
1	CytokinesIBA 01/2002
1	NitritesIBA 01/2002
1	Peroxynitrous Acid (Peroxynitrite)IBA 01/2002
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 01/2002
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2002
1	Proteins (Proteins, Gene)FDA Link 01/2002

Therapy/Procedure

2	Therapeutics 09/2017 - 06/2016